Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials

Background and aims: We aimed to evaluate the association between anti-inflammatory therapies and the inci-dence of cardiovascular events in patients with established cardiovascular disease (CVD) or high cardiovascular risks.Methods: Literature retrieval was conducted in PubMed, Medline, Embase, the Cochrane Central Register of Controlled Trials and Clinicaltrial.gov website from the inception to December 2022. Randomized controlled trials comparing anti-inflammatory therapies with placebo in patients with established CVD or high cardiovas-cular risks were included. The results of the meta-analysis were computed as the risk ratio (RR) with 95% confidence interval (CI).Results: Compared with placebo, anti-inflammatory therapies were associated with decreased incidence of myocardial infarction (MI) (RR = 0.93, 95% CI, 0.88 to 0.98), which was mainly driven by therapies targeting central IL-6 signaling pathway (RR = 0.83, 95% CI, 0.74 to 0.93). IL-1 inhibitors treatment was associated with reduced risks of heart failure (RR = 0.38, 95% CI, 0.18 to 0.80) while lower incidence of stroke was observed in patients with colchicine treatment (RR = 0.47, 95% CI, 0.28 to 0.77). MI events were less frequent in patients over 65 years of age (RR = 0.90, 95% CI, 0.83 to 0.98) or with follow-up duration over 1 year (RR = 0.90, 95% CI, 0.85 to 0.96) when comparing anti-inflammatory therapies with placebo.Conclusions: Anti-inflammatory therapies, especially those targeting the central IL-6 signaling pathway, may serve as promising treating strategies to ameliorate the risk of MI. IL-1 inhibitor and colchicine were associated with decreased risks of heart failure and stroke, respectively. MI risk reduction by anti-inflammatory therapies seemed to be more prominent in older patients with long follow-up duration.

Automated summary

This study evaluated the association between anti-inflammatory therapies and the incidence of cardiovascular events in patients with established cardiovascular disease or high cardiovascular risks. The results showed that anti-inflammatory therapies were associated with a decreased incidence of myocardial infarction, especially those targeting the central IL-6 signaling pathway. IL-1 inhibitor treatment was associated with a reduced risk of heart failure, while colchicine treatment was associated with a lower incidence of stroke. The risk reduction of myocardial infarction by anti-inflammatory therapies appeared to be more prominent in older patients with long follow-up duration.